title: Exposure of Allium cepa root cells to zidovudine or nevirapine induces cytogenotoxic changes.
abstract: Antiretroviral drugs have proved useful in the clinical management of HIV-infected persons, though there are concerns about the effects of exposure to these DNA-reactive drugs. We investigated the potential of the plant model Allium cepa root tip assay to demonstrate the cytogenotoxicity of zidovudine and nevirapine and as a replace-reduce-refine programme amenable to resource-poor research settings. Cells mitotic index were determined in squashed root cells from Allium cepa bulbs exposed to zidovudine or nevirapine for 48 hr. The concentration of zidovudine and nevirapine inhibiting 50% root growth after 96 hr exposure was 65.0 µM and 92.5 µM respectively. Root length of all antiretroviral-exposed roots after 96 hr exposure was significantly shorter than the unexposed roots while additional root growth during a subsequent 48 hr recovery period in the absence of drug was not significantly different. By ANOVA, there was a significant association between percentage of cells in mitosis and zidovudine dose (p=0.004), but not nevirapine dose (p=0.68). Chromosomal aberrations such as sticky chromosomes, chromatin bridges, multipolar mitoses and binucleated cells were observed in root cells exposed to zidovudine and nevirapine for 48 hr. The most notable chromosomal aberration was drug-related increases in sticky chromosomes. Overall, the study showed inhibition in root length growth, changes in the mitotic index, and the induction of chromosomal aberrations in Allium bulbs treated for 96 hr or 48 hr with zidovudine and nevirapine. The study reveals generalized cytogenotoxic damage induced by exposure to zidovudine and nevirapine, and further show that the two compounds differ in their effects on mitosis and the types of chromosomal aberrations induced.
authors.affiliation: Human Virology Laboratory, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
authors.forename: Chika K
authors.initials: CK
authors.lastname: Onwuamah
authors.affiliation: Clinical Sciences Division, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
authors.forename: Sabdat O
authors.initials: SO
authors.lastname: Ekama
authors.affiliation: Human Virology Laboratory, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
authors.forename: Rosemary A
authors.initials: RA
authors.lastname: Audu
authors.affiliation: Clinical Sciences Division, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
authors.forename: Oliver C
authors.initials: OC
authors.lastname: Ezechi
authors.affiliation: Carcinogen-DNA Interactions Section, LCBG, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, United States of America.
authors.forename: Miriam C
authors.initials: MC
authors.lastname: Poirier
authors.affiliation: Department of Cell Biology & Genetics, University of Lagos, Akoka, Lagos, Nigeria.
authors.forename: Peter G C
authors.initials: PG
authors.lastname: Odeigah
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D004249:DNA Damage; D004353:Drug Evaluation, Preclinical; D020128:Inhibitory Concentration 50; D008938:Mitosis / Q000187:drug effects; D008940:Mitotic Index; D009153:Mutagens / Q000494:pharmacology; D019829:Nevirapine / Q000494:pharmacology*; D019697:Onions / Q000166:cytology / Q000187:drug effects; D018517:Plant Roots / Q000166:cytology / Q000187:drug effects; D015215:Zidovudine / Q000494:pharmacology*
chemical_list: D019380:Anti-HIV Agents; D009153:Mutagens; D015215:Zidovudine; D019829:Nevirapine